FDA NEWS ALERT.com... news and blog postings from the publisher of FDA Webview and FDA Review
HomeAbout usContact UsAdvertising

fdareviewart.JPG

FDA WATCH...
News and blog postings on FDA regulatory
and compliance activities from the publisher
of FDA Webview and FDA Review

Archive Newer | Older
FDA Ad Division Shows No Slowing Down
02/04/2010 Fresh on the heels of last year's record setting pace for citing drug manufacturer advertising and promotion violations, FDA's drug advertising division is at it again 2/3 with the release of four new violation letters to industry. Read More ...
9:42 am 
Archive Newer | Older


News reports from FDA Webview (www.fdaweb.com)

 
 
TXT B. Braun Medical Class 1 Recall [116 Words]
02/01/2011
 
 
TXT Inspection Finds Problems at Baxter Puerto Rico Plants [297 Words]
02/01/2011
 
 
TXT Risk Signals from 2010 Third Quarter Listed [112 Words]
02/01/2011
 
 
TXT FDA Touts Progress on ‘Paperless’ Review Environment [76 Words]
02/01/2011
 
 
TXT Optivia, FDA Collaborate on Drug-Dietary Supplement Interactions [158 Words]
02/01/2011
 
 
TXT Orphan Drug Designations Up, Approvals Down in 2010 [176 Words]
02/01/2011
 
 
TXT FDA Rejects Orexigen's Obesity Drug Contrave [276 Words]
02/01/2011
 
 
TXT SPL Warned Over CGMP Problems [254 Words]
02/01/2011
 
 
TXT Risk Signals from 2010 Third Quarter Listed [112 Words]
02/01/2011
 

FREE NEWSLETTER: Enter email address:

We bring the FDA to you
fdalive2.gif
click image to view available FDA meetings



Our Subscription Newsletters:

fdaweb.JPG
Daily FDA and Industry Regulatory and Compliance News

fdareview.JPG
The most authoritative FDA news analysis each month

fdaupdatemain.JPG
Weekly easy to ready news capsules

This site  The Web 

Home
About Us
Contact Us
Referrals


FDANewsAlert.com is published by Ferdic Inc.
Ferdic Inc. (publishers of Dickinson's FDA Webview (www.fdaweb.com) and FDA Review
Camp Hill, Pa 17011
info@fdaweb.com